{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:45:21Z","timestamp":1786985121201,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005808","name":"IIT Bombay","doi-asserted-by":"publisher","award":["DO\/2018-WRCB002-028"],"award-info":[{"award-number":["DO\/2018-WRCB002-028"]}],"id":[{"id":"10.13039\/501100005808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005808","name":"IIT Bombay","doi-asserted-by":"publisher","award":["DO\/2022-WRCB002-074"],"award-info":[{"award-number":["DO\/2022-WRCB002-074"]}],"id":[{"id":"10.13039\/501100005808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011627","name":"Industrial Research and Consultancy Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024793","name":"Wadhwani Research Centre for Bioengineering, Indian Institute of Technology Bombay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007179","name":"Advanced Centre for Treatment, Research and Education in Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bioadv.2025.214489","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T07:02:56Z","timestamp":1756969376000},"page":"214489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Sustained and localized delivery of gemcitabine using chitosan-PVA-TPP polymeric implant enhances antitumor efficacy and delays surgical relapse in pancreatic cancer"],"prefix":"10.1016","volume":"179","author":[{"given":"Archana","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Mal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panchali","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parikshit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal K.","family":"Valvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali Krishna","family":"Chilakapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdip","family":"Bandyopadhyaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2025.214489_bb0005","author":"Institute, N.C"},{"key":"10.1016\/j.bioadv.2025.214489_bb0010","series-title":"An Epidemiological Review of Pancreatic Cancer with Special Reference to India","first-page":"99","volume":"73(1)","author":"Gaidhani","year":"2021"},{"key":"10.1016\/j.bioadv.2025.214489_bb0015","author":"Carlos Fernandez-del Castillo"},{"key":"10.1016\/j.bioadv.2025.214489_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21040522","article-title":"Delivery of gemcitabine prodrugs employing mesoporous silica nanoparticles","volume":"21","author":"Malfanti","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioadv.2025.214489_bb0025","unstructured":"Mamon, H. Initial management of locally advanced unresectable or borderline resectable exocrine pancreatic cancer. [cited 2024 24\/06\/2024]; Available from: https:\/\/sso.uptodate.com\/contents\/initial-management-of-locally-advanced-unresectable-or-borderline-resectable-exocrine-pancreatic-cancer?search=initial+management+of+locally+advanced&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1."},{"key":"10.1016\/j.bioadv.2025.214489_bb0030","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-016-3003-0","article-title":"Pharmacokinetics and pharmacogenetics of gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective","volume":"78","author":"Ciccolini","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jddst.2015.09.004","article-title":"Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems","volume":"32","author":"Arpicco","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14740330802374262","article-title":"Gemcitabine: vascular toxicity and prothrombotic potential","volume":"7","author":"Dasanu","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bioadv.2025.214489_bb0045","series-title":"Pharmaceuticals Special Issue \u201cAnticancer Drugs\u201d","author":"Meegan","year":"2019"},{"key":"10.1016\/j.bioadv.2025.214489_bb0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.gendis.2015.07.003","article-title":"Promising molecular mechanisms responsible for gemcitabine resistance in cancer","volume":"2","author":"Jia","year":"2015","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioadv.2025.214489_bb0055","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.21873\/anticanres.13726","article-title":"Induction of metastasis by low-dose gemcitabine in a pancreatic cancer orthotopic mouse model: an opposite effect of chemotherapy","volume":"39","author":"Sugisawa","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bioadv.2025.214489_bb0060","author":"Xu"},{"key":"10.1016\/j.bioadv.2025.214489_bb0065","series-title":"Transferrin-Conjugated Polymer-Coated Mesoporous Silica Nanoparticles Loaded with Gemcitabine for Killing Pancreatic Cancer Cells","author":"Saini","year":"2019"},{"key":"10.1016\/j.bioadv.2025.214489_bb0070","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1166\/jnn.2020.17381","article-title":"Development of mesoporous silica nanoparticles of tunable pore diameter for superior gemcitabine drug delivery in pancreatic cancer cells","volume":"20","author":"Saini","year":"2019","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0075","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1021\/acsabm.0c00515","article-title":"Noninvasive preclinical evaluation of targeted nanoparticles for the delivery of curcumin in treating pancreatic cancer","volume":"3","author":"Prabhuraj","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bioadv.2025.214489_bb0080","doi-asserted-by":"crossref","first-page":"2307263","DOI":"10.1002\/adma.202307263","article-title":"Dendritic nanomedicine with boronate bonds for augmented chemo-immunotherapy via synergistic modulation of tumor immune microenvironment","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2025.214489_bb0085","article-title":"Dendritic polymer-based nanomedicines remodel the tumor stroma: improve drug penetration and enhance antitumor immune response","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2025.214489_bb0090","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1200\/JCO.2006.07.0201","article-title":"Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer","volume":"24","author":"Abou-Alfa","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0095","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/01635581.2010.513802","article-title":"Curcumin and gemcitabine in patients with advanced pancreatic cancer","volume":"62","author":"Epelbaum","year":"2010","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.bioadv.2025.214489_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120043","article-title":"Recent advances and prospects in gemcitabine drug delivery systems","volume":"592","author":"Paroha","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214489_bb0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14796694.1.1.7","article-title":"Drug evaluation role of gemcitabine in cancer therapy","volume":"1","author":"Toschi","year":"2005","journal-title":"Future Oncol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0110","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1073\/pnas.1221526110","article-title":"Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro","volume":"110","author":"Nguyen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioadv.2025.214489_bb0115","doi-asserted-by":"crossref","unstructured":"A. Bulle, K.-H. Lim, Beyond Just a Tight Fortress: Contribution of Stroma to Epithelial-mesenchymal Transition in Pancreatic Cancer, (n.d.). doi:https:\/\/doi.org\/10.1038\/s41392-020-00341-1.","DOI":"10.1038\/s41392-020-00341-1"},{"key":"10.1016\/j.bioadv.2025.214489_bb0120","series-title":"Stromal Barriers to Nanomedicine Penetration in the Pancreatic Tumor Microenvironment","author":"Tanaka","year":"2018"},{"key":"10.1016\/j.bioadv.2025.214489_bb0125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jconrel.2024.01.072","article-title":"Locoregional drug delivery for cancer therapy: preclinical progress and clinical translation","volume":"367","author":"Shaha","year":"2024","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.bioadv.2025.214489_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201600766","article-title":"Biomaterial-based implantable devices for cancer therapy","volume":"6","author":"Chew","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioadv.2025.214489_bb0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.msec.2016.01.063","article-title":"Biomaterial-based regional chemotherapy: local anticancer drug delivery to enhance chemotherapy and minimize its side-effects","volume":"62","author":"Krukiewicz","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioadv.2025.214489_bb0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","article-title":"Clinical translation of long-acting drug delivery formulations","volume":"7","author":"Li","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bioadv.2025.214489_bb0145","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1080\/10717544.2022.2075984","article-title":"Biodegradable gemcitabine-loaded microdevice with sustained local drug delivery and improved tumor recurrence inhibition abilities for postoperative pancreatic tumor treatment","volume":"29","author":"Kong","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioadv.2025.214489_bb0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ijbiomac.2016.05.054","article-title":"Why chitosan? From properties to perspective of mucosal drug delivery","volume":"91","author":"Kumar","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2020.06.012","article-title":"Chitosan hydrogels for sustained drug delivery","volume":"326","author":"Peers","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214489_bb0160","series-title":"Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications: Volume 1: Types and Triggers","first-page":"581","article-title":"Chitosan as responsive polymer for drug delivery applications","author":"Hasnain","year":"2018"},{"key":"10.1016\/j.bioadv.2025.214489_bb0165","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ijbiomac.2019.02.060","article-title":"Chitosan nanopolymers: an overview of drug delivery against cancer","volume":"130","author":"Shanmuganathan","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0170","series-title":"Nanofiltration Membranes Based on Poly(Vinyl Alcohol) and Ionic Polymers","author":"Jegal","year":"1999"},{"key":"10.1016\/j.bioadv.2025.214489_bb0175","series-title":"Synthesis and Characterization of Chitosan-polyvinyl Alcohol Blended with Cloisite 30B for Controlled Release of the Anticancer Drug Curcumin","first-page":"414","volume":"2(4)","author":"Parida","year":"2011"},{"key":"10.1016\/j.bioadv.2025.214489_bb0180","series-title":"Properties and Applications of Polyvinyl Alcohol, Halloysite Nanotubes and Their Nanocomposites","author":"Gaaz","year":"2015"},{"key":"10.1016\/j.bioadv.2025.214489_bb0185","series-title":"Chitosan and Polyvinyl Alcohol Composite Films Containing Nitrofurazone; Preparation and Evaluation","author":"Kouchak","year":"2014"},{"key":"10.1016\/j.bioadv.2025.214489_bb0190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.nano.2011.03.009","article-title":"Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy","volume":"7","author":"Arya","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214489_bb0195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/2230-973X.85967","article-title":"In vitro and in vivo evaluation of chitosan buccal films of ondansetron hydrochloride","volume":"1","author":"Koland","year":"2011","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.bioadv.2025.214489_bb0200","first-page":"4643","article-title":"Noninvasive preclinical evaluation of targeted nanoparticles for the delivery of curcumin in treating pancreatic cancer","volume":"2020","author":"Mal","year":"2020","journal-title":"ACS Appl. Bio Mater"},{"key":"10.1016\/j.bioadv.2025.214489_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-62703-287-2_11","article-title":"Development of orthotopic pancreatic tumor mouse models","volume":"980","author":"Qiu","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0210","first-page":"1","article-title":"An orthotopic resectional mouse model of pancreatic cancer","volume":"2020","author":"Pang","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bioadv.2025.214489_bb0215","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1245\/s10434-009-0856-z","article-title":"Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films","volume":"17","author":"Liu","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2010.02.022","article-title":"Prevention of in vivo lung tumor growth by prolonged local delivery of hydroxycamptothecin using poly(ester-carbonate)-collagen composites","volume":"144","author":"Wolinsky","year":"2010","journal-title":"J. Control. Release."},{"key":"10.1016\/j.bioadv.2025.214489_bb0225","series-title":"Biosurfaces","first-page":"329","article-title":"Physical, Thermal, and Mechanical Properties of Polymers","author":"Balani","year":"2014"},{"key":"10.1016\/j.bioadv.2025.214489_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","article-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","volume":"73","author":"Huang","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214489_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-017-0080","article-title":"A fully functional drug-eluting joint implant","volume":"1","author":"Suhardi","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioadv.2025.214489_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084118","article-title":"Role of polymer concentration and crosslinking density on release rates of small molecule drugs","volume":"23","author":"Briggs","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2025.214489_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1175563","article-title":"Association between pH regulation of the tumor microenvironment and immunological state","volume":"13","author":"Hosonuma","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0250","series-title":"IOP Conf Ser Mater Sci Eng","article-title":"Modification of chitosan by swelling and crosslinking using epichlorohydrin as heavy metal Cr (VI) adsorbent in batik industry wastes","author":"Hastuti","year":"2016"},{"issue":"3","key":"10.1016\/j.bioadv.2025.214489_bb0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1015887213431","article-title":"Hydrogels: swelling, drug loading, and release","volume":"9","author":"S.W.","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioadv.2025.214489_bb0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eurpolymj.2014.10.017","article-title":"Characterization and swelling performance of physically stabilized electrospun poly(vinyl alcohol)\/chitosan nanofibres","volume":"61","author":"\u00c7ay","year":"2014","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214489_bb0265","series-title":"Proceedings of the LACCEI International Multi-Conference for Engineering, Education and Technology, Latin American and Caribbean Consortium of Engineering Institutions","article-title":"Evaluation of industrial processes to obtain chitin and chitosan","author":"Colina","year":"2018"},{"key":"10.1016\/j.bioadv.2025.214489_bb0270","series-title":"Preparation and characterization of polyvinyl alcohol-chitosan composite films reinforced with cellulose nanofiber","first-page":"644","volume":"9(8)","author":"Choo","year":"2016"},{"key":"10.1016\/j.bioadv.2025.214489_bb0275","doi-asserted-by":"crossref","DOI":"10.1111\/1750-3841.12395","article-title":"Preparation of chitosan-TPP microspheres as resveratrol carriers","volume":"79","author":"Cho","year":"2014","journal-title":"J. Food Sci."},{"key":"10.1016\/j.bioadv.2025.214489_bb0280","author":"Salazar"},{"key":"10.1016\/j.bioadv.2025.214489_bb0285","article-title":"Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells","volume":"55","author":"Affram","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0290","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ijbiomac.2020.05.088","article-title":"The mutual effect of the crosslinker and biopolymer concentration on the desired hydrogel properties","volume":"159","author":"Kopa\u010d","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0295","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/D2CB00030J","article-title":"A library of Rhodamine6G-based pH-sensitive fluorescent probes with versatile in vivo and in vitro applications","volume":"3","author":"Swanson","year":"2022","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0300","author":"Montano"},{"key":"10.1016\/j.bioadv.2025.214489_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05103-1","article-title":"Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioadv.2025.214489_bb0310","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/carcin\/bgx065","article-title":"Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression","volume":"38","author":"Yoshida","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bioadv.2025.214489_bb0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.03.044","article-title":"A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma","volume":"93","author":"Indolfi","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214489_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00006","article-title":"Three-dimensional in vitro cell culture models in drug discovery and drug repositioning","volume":"9","author":"Langhans","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0325","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1087057117696795","article-title":"Three-dimensional cell cultures in drug discovery and development","volume":"22","author":"Fang","year":"2017","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.bioadv.2025.214489_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.597673","article-title":"EpCAM-mediated cellular plasticity promotes radiation resistance and metastasis in breast cancer","volume":"8","author":"Mal","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0335","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer","volume":"69","author":"Arumugam","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioadv.2025.214489_bb0340","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","article-title":"DNA damage-induced cell death by apoptosis","volume":"12","author":"Roos","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bioadv.2025.214489_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jinorgbio.2015.01.013","article-title":"DNA damage and induction of apoptosis in pancreatic cancer cells by a new dinuclear bis(triazacyclonane) copper complex","volume":"145","author":"Montagner","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioadv.2025.214489_bb0350","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1158\/1535-7163.MCT-14-0420","article-title":"Mechanisms of overcoming intrinsic resistance to gemcitabine in pancreatic ductal adenocarcinoma through the redox modulation","volume":"14","author":"Ju","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioadv.2025.214489_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051605","article-title":"Local delivery of gemcitabine inhibits pancreatic and cholangiocarcinoma tumor growth by promoting epidermal growth factor receptor degradation","volume":"21","author":"Jang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2025.214489_bb0360","doi-asserted-by":"crossref","first-page":"9510","DOI":"10.1158\/0008-5472.CAN-05-0989","article-title":"In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant","volume":"65","author":"Bergman","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioadv.2025.214489_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102486","article-title":"Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review","volume":"14","author":"Koltai","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.bioadv.2025.214489_bb0370","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/mc.23090","article-title":"Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype","volume":"58","author":"El Amrani","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bioadv.2025.214489_bb0375","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1039\/c1mb05125c","article-title":"Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells","volume":"7","author":"Chen","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.bioadv.2025.214489_bb0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.597673","article-title":"EpCAM-mediated cellular plasticity promotes radiation resistance and metastasis in breast cancer","volume":"8","author":"Mal","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0390","article-title":"Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines","volume":"7","author":"Shen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bioadv.2025.214489_bb0395","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41418-024-01284-8","article-title":"Diverse functions of cytochrome c in cell death and disease","volume":"31","author":"Zhou","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioadv.2025.214489_bb0400","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","article-title":"Cytochrome C-mediated apoptosis","volume":"73","author":"Jiang","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bioadv.2025.214489_bb0405","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1172\/JCI127201","article-title":"Adipocyte and lipid metabolism in cancer drug resistance","volume":"129","author":"Cao","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bioadv.2025.214489_bb0410","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cac2.12360","article-title":"Lipid metabolism in pancreatic cancer: emerging roles and potential targets","volume":"42","author":"Yin","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioadv.2025.214489_bb0415","series-title":"De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer","first-page":"5503","volume":"77(20)","author":"Tadros","year":"2017"},{"key":"10.1016\/j.bioadv.2025.214489_bb0420","article-title":"Lipid metabolism as a target for cancer drug resistance: progress and prospects","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2025.214489_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213153","article-title":"Photothermal therapy (PTT) is an effective treatment measure against solid tumors which fails to respond conventional chemo\/radiation therapies in clinic","volume":"143","author":"Mishra","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioadv.2025.214489_bb0430","series-title":"Handb Exp Pharmacol","first-page":"55","article-title":"General Principles of Preclinical Study Design","author":"Huang","year":"2020"},{"key":"10.1016\/j.bioadv.2025.214489_bb0435","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2023.11.028","article-title":"Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer","volume":"365","author":"Wang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214489_bb0440","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2019.05.018","article-title":"Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer","volume":"305","author":"Tang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214489_bb0445","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2019.07.014","article-title":"Tumor-specific delivery of gemcitabine with activatable liposomes","volume":"309","author":"Tucci","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214489_bb0450","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmjstel-2018-000370","article-title":"Using clinical simulation to study how to improve quality and safety in healthcare","volume":"6","author":"Lam\u00e9","year":"2020","journal-title":"BMJ Simul. Technol. Enhanc. Learn."},{"key":"10.1016\/j.bioadv.2025.214489_bb0455","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/cam4.200","article-title":"Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study","volume":"3","author":"Culakova","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.bioadv.2025.214489_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpsurg.2025.101746","article-title":"Clinical analysis of sustained-release 5-fluorouracil implants during surgery for advanced gastric cancer","volume":"66","author":"Huang","year":"2025","journal-title":"Curr. Probl. Surg."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:57:00Z","timestamp":1760075820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825003164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":92,"alternative-id":["S2772950825003164"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214489","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained and localized delivery of gemcitabine using chitosan-PVA-TPP polymeric implant enhances antitumor efficacy and delays surgical relapse in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214489"}}